Nifty
Sensex
:
:
11767.75
40145.50
-162.60 (-1.36%)
-540.00 (-1.33%)

Pesticides & Agrochemicals

Rating :
76/99  (View)

BSE: 532067 | NSE: Not Listed

381.00
-15.65 (-3.95%)
26-Oct-2020 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  404.00
  •  410.00
  •  376.85
  •  396.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  51839
  •  197.51
  •  517.00
  •  54.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 283.21
  • 9.65
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 277.34
  • 0.19%
  • 4.77

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 38.35%
  • 9.28%
  • 47.23%
  • FII
  • DII
  • Others
  • 2.93%
  • 0.00%
  • 2.21%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.03
  • 10.75
  • 7.55

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.80
  • 43.88
  • 11.43

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 25.71
  • 77.21
  • 30.88

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.25
  • 18.81
  • 14.67

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.32
  • 3.19
  • 4.22

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.68
  • 11.46
  • 12.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
53
6
839%
7
6
10%
7
5
32%
10
8
23%
Expenses
16
3
378%
4
4
16%
5
4
28%
7
6
20%
EBITDA
36
2
1564%
2
2
1%
2
2
40%
2
2
34%
EBIDTM
69%
39%
35%
38%
34%
32%
25%
23%
Other Income
0
0
300%
1
0
-
0
0
-85%
1
0
33%
Interest
0
0
-22%
0
0
-21%
0
0
-50%
0
0
-56%
Depreciation
0
0
0%
0
0
-25%
0
0
-21%
0
0
56%
PBT
36
2
1750%
3
2
58%
2
2
27%
3
2
36%
Tax
9
1
1549%
1
1
14%
0
0
246%
1
0
6%
PAT
27
1
1815%
2
1
84%
2
2
9%
2
2
47%
PATM
51%
25%
34%
20%
25%
31%
23%
20%
EPS
36.26
1.89
1819%
3.04
1.65
84%
2.32
2.12
9%
3.00
2.04
47%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
76
29
23
23
16
17
19
22
20
21
21
Net Sales Growth
207%
24%
0%
44%
-7%
-8%
-14%
8%
-5%
-1%
 
Cost Of Goods Sold
22
13
11
12
0
10
12
15
13
12
12
Gross Profit
54
16
12
11
16
7
7
7
7
9
9
GP Margin
71%
54%
53%
46%
99%
41%
37%
31%
37%
42%
42%
Total Expenditure
33
20
16
18
14
16
18
21
19
20
20
Power & Fuel Cost
-
0
0
0
0
0
0
0
0
0
0
% Of Sales
-
1%
1%
1%
1%
1%
1%
1%
1%
1%
1%
Employee Cost
-
3
3
2
2
2
2
2
2
2
1
% Of Sales
-
10%
11%
9%
11%
11%
10%
9%
10%
7%
5%
Manufacturing Exp.
-
0
0
0
9
0
0
0
0
2
2
% Of Sales
-
0%
0%
1%
53%
1%
0%
0%
0%
11%
11%
General & Admin Exp.
-
1
1
1
1
0
0
0
0
0
1
% Of Sales
-
3%
3%
3%
4%
3%
2%
2%
2%
2%
3%
Selling & Distn. Exp.
-
1
1
1
1
1
1
1
1
1
2
% Of Sales
-
3%
2%
3%
4%
5%
7%
6%
7%
3%
9%
Miscellaneous Exp.
-
1
1
1
2
2
2
2
2
3
2
% Of Sales
-
5%
5%
5%
10%
11%
9%
7%
11%
13%
5%
EBITDA
44
9
7
5
3
2
1
1
1
1
2
EBITDA Margin
57%
32%
31%
23%
16%
9%
7%
6%
6%
5%
8%
Other Income
2
2
1
0
0
0
0
0
0
0
0
Interest
0
0
0
1
1
1
1
1
1
1
0
Depreciation
1
1
1
0
0
0
0
0
0
0
0
PBT
44
10
7
5
1
0
0
0
1
0
1
Tax
11
2
2
1
0
0
0
0
0
0
0
Tax Rate
25%
23%
25%
24%
19%
23%
20%
14%
32%
104%
33%
PAT
33
8
5
3
1
0
0
1
1
0
1
PAT before Minority Interest
29
8
5
3
1
0
0
0
0
0
1
Minority Interest
-4
0
0
0
0
0
0
0
0
0
0
PAT Margin
44%
27%
23%
15%
7%
3%
2%
3%
4%
2%
4%
PAT Growth
479%
47%
53%
204%
157%
22%
-40%
-28%
137%
-55%
 
EPS
44.63
10.25
6.99
4.57
1.51
0.59
0.48
0.80
1.11
0.47
1.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
32
22
18
11
10
10
10
10
9
8
Share Capital
7
6
6
6
6
6
6
6
6
6
Total Reserves
25
16
7
5
4
4
4
3
3
2
Non-Current Liabilities
2
3
3
4
3
3
3
2
2
2
Secured Loans
0
0
0
1
0
0
0
0
0
0
Unsecured Loans
1
2
2
2
3
2
2
1
1
1
Long Term Provisions
0
0
0
0
0
0
0
0
0
0
Current Liabilities
8
10
9
11
10
12
11
11
11
8
Trade Payables
3
4
3
4
5
6
7
6
7
5
Other Current Liabilities
0
0
0
0
1
0
0
0
0
0
Short Term Borrowings
2
4
3
6
5
5
4
4
4
2
Short Term Provisions
2
2
1
0
0
0
0
0
0
1
Total Liabilities
45
36
30
26
24
25
24
23
22
19
Net Block
4
4
4
3
3
4
4
4
4
4
Gross Block
9
8
8
4
6
6
6
6
6
5
Accumulated Depreciation
5
4
4
0
3
3
2
2
2
2
Non Current Assets
6
4
4
4
4
4
4
4
4
4
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Non Current Investment
1
0
0
0
0
0
0
0
0
0
Long Term Loans & Adv.
0
0
0
0
0
0
0
0
0
0
Other Non Current Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
39
32
26
22
21
21
20
19
18
15
Current Investments
0
0
0
0
0
0
0
0
0
0
Inventories
4
5
4
4
3
4
4
4
4
4
Sundry Debtors
20
18
16
14
13
14
13
12
11
10
Cash & Bank
9
3
2
0
0
0
0
0
1
0
Other Current Assets
6
4
0
0
3
3
3
2
2
1
Short Term Loans & Adv.
2
1
5
3
3
3
3
2
2
1
Net Current Assets
31
22
18
11
10
9
9
8
7
7
Total Assets
45
36
30
26
24
25
24
23
22
19

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
7
4
2
1
1
0
0
-1
0
0
PBT
10
7
5
1
0
0
0
1
0
1
Adjustment
1
1
1
1
1
1
1
1
1
1
Changes in Working Capital
-1
-3
-3
-2
-1
-1
-1
-2
-1
-2
Cash after chg. in Working capital
9
5
3
1
1
0
0
-1
1
0
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-2
-2
-1
0
0
0
0
0
0
0
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-1
-1
-1
0
0
0
0
0
-1
-1
Net Fixed Assets
0
0
0
0
0
0
0
0
0
Net Investments
-2
0
-1
0
0
0
0
0
0
Others
2
-1
0
0
0
0
0
0
0
Cash from Financing Activity
1
-1
0
0
-1
0
0
0
1
1
Net Cash Inflow / Outflow
7
2
1
0
0
0
0
-1
1
0
Opening Cash & Equivalents
2
0
0
0
0
0
0
1
0
0
Closing Cash & Equivalent
9
2
2
0
0
0
0
0
1
0

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
43
35
21
18
16
16
16
15
14
13
ROA
19%
16%
12%
5%
1%
1%
2%
2%
0%
4%
ROE
28%
29%
28%
10%
3%
2%
4%
4%
0%
9%
ROCE
32%
28%
24%
13%
7%
7%
7%
8%
7%
14%
Fixed Asset Turnover
3.38
2.93
4.23
3.54
3.03
3.37
4.02
3.75
4.15
4.39
Receivable days
243
274
239
291
262
234
188
185
161
158
Inventory Days
57
68
60
77
70
72
64
71
63
57
Payable days
74
89
86
133
141
142
124
144
119
103
Cash Conversion Cycle
226
253
213
234
191
163
128
112
105
112
Total Debt/Equity
0.11
0.28
0.42
0.78
0.74
0.74
0.69
0.62
0.62
0.42
Interest Cover
31
16
7
2
2
1
2
2
1
3

News Update


  • Kilpest India‚Äôs arm extends agreement with HS Biolabs Manchestor
    12th Oct 2020, 09:31 AM

    HS BioLabs will begin selling all TRUPCR CE IVD Kits across select markets in the European region

    Read More
  • Kilpest India sells 8.68 lakh Covid-19 RT-PCR tests in September
    3rd Oct 2020, 10:30 AM

    Earlier, in the month of August the company had sold 4.22 lakh Covid-19 RT-PCR test

    Read More
  • Kilpest India sells 4,22,000 Covid-19 RT-PCR tests in August
    3rd Sep 2020, 16:32 PM

    The company has successfully completed all previous Government orders

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.